878 related articles for article (PubMed ID: 26964154)
1. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography in presurgical localization of epileptic foci.
Csaba J
Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.
Ryvlin P; Bouvard S; Le Bars D; De Lamérie G; Grégoire MC; Kahane P; Froment JC; Mauguière F
Brain; 1998 Nov; 121 ( Pt 11)():2067-81. PubMed ID: 9827767
[TBL] [Abstract][Full Text] [Related]
5. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
[TBL] [Abstract][Full Text] [Related]
6. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy.
Juhász C; Chugani DC; Muzik O; Watson C; Shah J; Shah A; Chugani HT
Neurology; 2000 Sep; 55(6):825-35. PubMed ID: 10994004
[TBL] [Abstract][Full Text] [Related]
7. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy.
Muzik O; da Silva EA; Juhasz C; Chugani DC; Shah J; Nagy F; Canady A; von Stockhausen HM; Herholz K; Gates J; Frost M; Ritter F; Watson C; Chugani HT
Neurology; 2000 Jan; 54(1):171-9. PubMed ID: 10636144
[TBL] [Abstract][Full Text] [Related]
8. Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis.
Yankam Njiwa J; Gray KR; Costes N; Mauguiere F; Ryvlin P; Hammers A
Neuroimage Clin; 2015; 7():122-31. PubMed ID: 25610774
[TBL] [Abstract][Full Text] [Related]
9. Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery?
van't Klooster MA; Huiskamp G; Zijlmans M; Debets RM; Comans EF; Bouvard S; Ryvlin P; Leijten FS
Epilepsy Res; 2014 Aug; 108(6):1095-105. PubMed ID: 24893829
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET and magnetoencephalography in presurgical workup of children with localization-related nonlesional epilepsy.
Widjaja E; Shammas A; Vali R; Otsubo H; Ochi A; Snead OC; Go C; Charron M
Epilepsia; 2013 Apr; 54(4):691-9. PubMed ID: 23398491
[TBL] [Abstract][Full Text] [Related]
11. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
[TBL] [Abstract][Full Text] [Related]
12. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
[TBL] [Abstract][Full Text] [Related]
13. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome.
Juhász C; Chugani DC; Muzik O; Shah A; Shah J; Watson C; Canady A; Chugani HT
Neurology; 2001 Jun; 56(12):1650-8. PubMed ID: 11425929
[TBL] [Abstract][Full Text] [Related]
14. Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy.
Ohta Y; Nariai T; Ishii K; Ishiwata K; Mishina M; Senda M; Hirakawa K; Ohno K
Ann Nucl Med; 2008 Jul; 22(6):495-503. PubMed ID: 18670856
[TBL] [Abstract][Full Text] [Related]
15. [11C]Flumazenil PET in patients with epilepsy with dual pathology.
Juhász C; Nagy F; Muzik O; Watson C; Shah J; Chugani HT
Epilepsia; 1999 May; 40(5):566-74. PubMed ID: 10386525
[TBL] [Abstract][Full Text] [Related]
16. Objective detection of epileptic foci by 18F-FDG PET in children undergoing epilepsy surgery.
Kumar A; Juhász C; Asano E; Sood S; Muzik O; Chugani HT
J Nucl Med; 2010 Dec; 51(12):1901-7. PubMed ID: 21078805
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography in partial epilepsies: the clinical point of view.
Koutroumanidis M; Binnie CD; Panayiotopoulos CP
Nucl Med Commun; 1998 Dec; 19(12):1123-6. PubMed ID: 9885801
[TBL] [Abstract][Full Text] [Related]
18. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study.
Bouvard S; Costes N; Bonnefoi F; Lavenne F; Mauguière F; Delforge J; Ryvlin P
Brain; 2005 Jun; 128(Pt 6):1330-43. PubMed ID: 15758035
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Analysis of [18F]FFMZ and [18F]FDG PET Studies in the Localization of Seizure Onset Zone in Drug-Resistant Temporal Lobe Epilepsy.
Avendaño-Estrada A; Velasco F; Velasco AL; Cuellar-Herrera M; Saucedo-Alvarado PE; Marquez-Franco R; Rivera-Bravo B; Ávila-Rodríguez MA
Stereotact Funct Neurosurg; 2019; 97(4):232-240. PubMed ID: 31722358
[TBL] [Abstract][Full Text] [Related]
20. Does F-18 FDG-PET substantially alter the surgical decision-making in drug-resistant partial epilepsy?
Menon RN; Radhakrishnan A; Parameswaran R; Thomas B; Kesavadas C; Abraham M; Vilanilam G; Sarma SP
Epilepsy Behav; 2015 Oct; 51():133-9. PubMed ID: 26276413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
